Literature DB >> 8559248

A common molecular basis for three inherited kidney stone diseases.

S E Lloyd1, S H Pearce, S E Fisher, K Steinmeyer, B Schwappach, S J Scheinman, B Harding, A Bolino, M Devoto, P Goodyer, S P Rigden, O Wrong, T J Jentsch, I W Craig, R V Thakker.   

Abstract

Kidney stones (nephrolithiasis), which affect 12% of males and 5% of females in the western world, are familial in 45% of patients and are most commonly associated with hypercalciuria. Three disorders of hypercalciuric nephrolithiasis (Dent's disease, X-linked recessive nephrolithiasis (XRN), and X-linked recessive hypophosphataemic rickets (XLRH)) have been mapped to Xp11.22 (refs 5-7). A microdeletion in one Dent's disease kindred allowed the identification of a candidate gene, CLCN5 (refs 8,9) which encodes a putative renal chloride channel. Here we report the investigation of 11 kindreds with these renal tubular disorders for CLCN5 abnormalities; this identified three nonsense, four missense and two donor splice site mutations, together with one intragenic deletion and one microdeletion encompassing the entire gene. Heterologous expression of wild-type CLCN5 in Xenopus oocytes yielded outwardly rectifying chloride currents, which were either abolished or markedly reduced by the mutations. The common aetiology for Dent's disease, XRN and XLRH indicates that CLCN5 may be involved in other renal tubular disorders associated with kidney stones.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8559248     DOI: 10.1038/379445a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  183 in total

1.  Male germ cells and photoreceptors, both dependent on close cell-cell interactions, degenerate upon ClC-2 Cl(-) channel disruption.

Authors:  M R Bösl; V Stein; C Hübner; A A Zdebik; S E Jordt; A K Mukhopadhyay; M S Davidoff; A F Holstein; T J Jentsch
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

2.  Distinct ion channel classes are expressed on the outer nuclear envelope of T- and B-lymphocyte cell lines.

Authors:  A Franco-Obregón; H W Wang; D E Clapham
Journal:  Biophys J       Date:  2000-07       Impact factor: 4.033

Review 3.  The renal tubular acidoses.

Authors:  R J Unwin; G Capasso
Journal:  J R Soc Med       Date:  2001-05       Impact factor: 5.344

4.  Alternative splicing of ClC-6 (a member of the CIC chloride-channel family) transcripts generates three truncated isoforms one of which, ClC-6c, is kidney-specific.

Authors:  J Eggermont; G Buyse; T Voets; J Tytgat; H De Smedt; G Droogmans; B Nilius
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

5.  Why oral calcium supplements may reduce renal stone disease: report of a clinical pilot study.

Authors:  C P Williams; D F Child; P R Hudson; G K Davies; M G Davies; R John; P S Anandaram; A R De Bolla
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

6.  Dent disease with compound heterozygous mutations leading to severe chronic renal failure in a female patient.

Authors:  Martin Holder; Martin Bald; Heinz E Leichter; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2003-11-25       Impact factor: 3.714

7.  Anion pathway and potential energy profiles along curvilinear bacterial ClC Cl- pores: electrostatic effects of charged residues.

Authors:  Gennady V Miloshevsky; Peter C Jordan
Journal:  Biophys J       Date:  2004-02       Impact factor: 4.033

Review 8.  Use of knock-out mouse models for the study of renal ion channels.

Authors:  H Barrière; M Tauc; P Poujeol
Journal:  J Membr Biol       Date:  2004-04-01       Impact factor: 1.843

9.  Update on the genetics of nephrolithiasis.

Authors:  Giuseppe Vezzoli; Teresa Arcidiacono; Vera Paloschi; Annalisa Terranegra; Rita Biasion; Laura Soldati
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

10.  ATP induces conformational changes in the carboxyl-terminal region of ClC-5.

Authors:  Leigh Wellhauser; Cesar Luna-Chavez; Christina D'Antonio; John Tainer; Christine E Bear
Journal:  J Biol Chem       Date:  2010-12-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.